跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ALF-1
首页
药物
ALF-1
ALF-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
TREATMENT OF PYROPTOSIS
EP 3768318 A1
申请人: JALAN RAJIV
优先权: 2018
EP
US
WO
3 件公开
Quaternary Ammonium Salt, Electrolyte, Electrolyte, Solution and Electrochemical Device
US 2008050657 A1
申请人: NISHIDA TETSUO
优先权: 2005
US
种Al‑<sup>18</sup>F标记融合肽及其应用
CN 103613671 B
申请人: 厦门大学附属第医院
优先权: 2013
CN
红螯螯虾抗脂多糖因子及其制备方法与应用
CN 105219779 B
申请人: 厦门大学
优先权: 2015
CN
一种双氟代碳酸乙烯酯的制备方法
CN 106905290 B
申请人: 江苏理文化工有限公司
优先权: 2017
CN
Radiolabeled subglutamic acid compound and application thereof in preparation of PET developer
CN 110551075 A
申请人: TANG GANGHUA
优先权: 2019
CN
Application of desmodium pulchellum in preparation of medicine for treating acute hepatic failure
CN 115006441 A
申请人: THE FIFTH AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIV
优先权: 2022
CN
Application of niclosamide in inhibition of acute hepatic failure
CN 116139116 A
申请人: XIANGYA HOSPITAL CENTRAL SOUTH UNIV
优先权: 2023
CN
Application of 25-hydroxycholesterol in preparation of medicine for inhibiting macrophage scavenger receptor 1
CN 117883454 A
申请人: THE FIRST AFFILIATED HOSPITAL COLLEGE OF MEDICINE ZHEJIANG UNIV
优先权: 2023
CN
Double-targeting tumor cell compound as well as preparation method and application thereof
CN 119301141 A
申请人: PEKING UNION MEDICAL COLLEGE HOSPITAL CAMS
优先权: 2024
CN
第 1 / 2 页
上一页
下一页
药物
反馈